Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter/Full-Year 2012 Financial Results and Medical Devices and Diagnostics Review
* Reuters is not responsible for the content in this press release.
For best results when printing this announcement, please click on the link below: http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20121221:nPnNY33161 NEW BRUNSWICK, N.J., Dec. 21, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Jan. 22, to discuss fourth-quarter and full-year 2012 financial results. The meeting will be hosted by Alex Gorsky, Chairman Elect of the Board and Chief Executive Officer; Dominic J. Caruso, Vice President, Finance and Chief Financial Officer; and Louise Mehrotra, Vice President, Investor Relations. In addition, Johnson & Johnson will host a review of its Medical Devices and Diagnostics business beginning at approximately 11:00 a.m. The program will include presentations by Gary Pruden, Worldwide Chairman, Global Surgery Group; Karen Licitra, Worldwide Chairman, Global Medical Solutions Group; and Michel Orsinger, Worldwide Chairman, DePuy Synthes Companies. Investors and other interested parties may access the broadcast of the live meeting by visiting the Company's website at www.investor.jnj.com. The webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads. A webcast and podcast replay will be available approximately two hours after the meeting concludes at www.investor.jnj.com. SOURCE Johnson & Johnson Media Contact: Al Wasilewski, +1-732-524-1130; Investor Contacts: Lesley Fishman, +1-732-524-3922, Louise Mehrotra, +1-732-524-6491, or Stan Panasewicz, +1-732-524-2524, Ellen Sipos, +1-732-524-3709